August

/Tag:August
­

August Newsletter

Let’s read Bionaturis Group latest news

IN THIS ISSUE

Biobide takes part in a research about Malaria funded by Melinda and Bill Gates

Biotechnology private investment increases

Let’s get to know…

Lucia Beltran Camacho, 22 years old, born in Tarifa (Cadiz). Degree at Biotechnology by Cadiz University.

 

 

 

-When you were a child, what did you want to be as an adult?
I have always loved everything related to music so I wanted to be a music teacher.
-What do you like the most about your job?
Learning and finding out new things every day.
-What are your future challenges?
Carrying on learning and progressing in order to work as a researcher.
-Your favourite dish
Lasagne.
-A place
Any beach.
-A film
‘Amelie’ ,by Jean-Pierre Jeunet.
-A historical figure
Rosalind Franklin.
-A book
‘The Silver Linings Playbook’, by Matthew Quick.
-A song
‘La piedra invisible’, by Izal.
-What do you usually do in your free time?
I like going to the cinema and spending time with my family and friends. If I have enough time, I love travelling and knowing new places.
-You can’t live without…
Chocolate.
-How do you imagine the world in 20 years?
A world where Science is more important than now and people bet on the progresses that it can offer.

Lucia has been doing a Lab Technician internship at Bionaturis since July, 2016.

Biobide takes part in a research about Malaria funded by Melinda
and Bill Gates

Biobide (Bionaturis Group) has recently participated in a drug discovery research against malaria, a disease that causes about 440,000 deaths each year worldwide. The collaborative international project supported by Melinda and Bill Gates has the main goal of going from Hits to Leads among a selection of 400 compounds –included in the Malaria Box- to which researchers from 30 different countries have had access in the latest two years. The final end is public institutions and […]

August 9th, 2016|Blog english|Comments Off on August Newsletter

August Newsletter

If you want to know Bionaturis’ latest news, here you are our August Newsletter

IN THIS ISSUE

Bionaturis’ vaccine against Visceral Canine Leishmaniasis, preventive and therapeutic
Andoni Cruz, BBD BioPhenix: “This new stage with Bionaturis is a big opportunity to grow in international markets”
Biotechnology strengthens its position in Spain

Let’s get to know…

Olaia Holgado Lozano, 31 years old, born in Donostia-San Sebastian, Degree in Environmental Sciences by the Basque Country University.

 

 

-When you were a child, what did you want to be as an adult?
Any occupation that let me help people, none in particular.
-What do you like the most about your job?
The workmates and the good work environment we enjoy.
-What are your future challenges?
Improving constantly our process and optmizing new essays with the zebrafish as an animal model.
-Your favourite dish
Potatoes omelette with courgette.
-A place
El Paseo Nuevo, in San Sebastian.
-A film
“Life is beatiful”, by Roberto Benigni.
-A historical figure
Pope John Paul II.
-A book
“I am a star”, by Inge Auerbacher.
-A song
‘Ironic’, by Alaniss Morissette.
-What do you usually do in your free time?
Enjoying my family.
-You can’t live without….
My family.
-How do you imagine the world in 20 years?
With more sensitivity to the human problems.

  She has been working as Lab Technician, Facility and Quality in BBD BioPhenix (acquired by Bionaturis) since February, 2007.

Bionaturis’ vaccine against Visceral Canine Leishmaniasis, preventive and therapeutic

Bionaturis continues the development of BNT005, a vaccine against Visceral Canine Leishmaniasis, a disease that affects dogs and is spread in Mediterranean countries as Spain, being registered an increasing rate of zoonosis (when an animal disease infects humans) lately. The visceral one is the most serious type of Leishmaniasis and it can be lethal if it is not treated well. It is caused by the parasites Leishmania and transmitted by the bite of the […]

August 12th, 2014|Blog english|Comments Off on August Newsletter

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR